Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Alignment Healthcare insider Dawn Maroney reported proposed sales of Common Stock via Form 144. The filing lists shares acquired on 03/13/2024 through RSU vesting (32,500 shares) and on 03/13/2025 through RSU vesting (39,785 shares).
The filing also documents recent 10b5-1 sales attributed to Dawn Maroney, including 30000 shares on 03/16/2026, 29,113 shares on 03/12/2026 (proceeds $507,925.32), and multiple earlier 2026 executions such as 30000 shares on 02/17/2026 and 30000 shares on 01/15/2026. The schedule shows additional disposals in January and December 2025.
Alignment Healthcare, Inc. reports proposed sales of Common Stock by affiliated holders via Form 144, listing multiple planned dispositions executed under a 10b5-1 sales plan and RSU vesting events. The filing lists specific transactions including 12/29/2025 sale of 605,648 shares ($11,351,466.51) and earlier 180,000-share sales on 01/12/2026, 02/10/2026, and 03/10/2026 under the 10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021. It also records RSU vesting acquisitions of 82,500 shares on 03/13/2024 and 91,398 shares on 03/13/2025.
Alignment Healthcare reported Rule 144 sale notices covering transactions by Andreas Wagner and planned dispositions of vested restricted stock units. The filing lists two recent sales: 21,118 shares sold on 03/04/2026 for $393,250.95 and 22,238 shares sold on 02/10/2026 for $455,211.86.
The filing also lists vested restricted stock units acquired on 03/13/2024 (15,000 shares) and 03/13/2025 (8,602 shares) that are described as securities to be sold.
Alignment Healthcare reported a Form 144 notice relating to proposed sales of Common Stock by Robert L. Scavo. The filing lists securities acquired on 03/13/2024 (17,500 shares) and 03/13/2025 (13,226 shares) via RSU vesting, and discloses recent sales of 4,044 shares on 03/12/2026 for $70,554.34 and 69,541 shares on 12/29/2025 for $1,303,384.48.
Alignment Healthcare, Inc. Chief Information Officer Robert L. Scavo reported selling 4,044 shares of common stock in open-market transactions to cover tax withholding obligations tied to vesting restricted stock units. The sales were not discretionary trades. After these transactions, he continues to hold 498,970 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported selling a total of 29,113 shares of common stock on March 12, 2026 in open-market transactions. Footnotes state these shares were sold solely to cover tax withholding obligations tied to vesting restricted stock units and were not discretionary trades. After these sales, she continues to hold 963,702 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. Chief Executive Officer John E. Kao reported selling a total of 48,899 shares of common stock in open-market transactions on March 12, 2026. The shares were sold at weighted-average prices of $17.476 and $16.9919 per share.
According to the disclosure, these sales were required to cover tax withholding obligations triggered by the vesting of restricted stock units and did not represent discretionary trading decisions by Mr. Kao. After the transactions, he held 1,519,480 shares directly.
The filing also reports 2,472,641 shares of common stock held indirectly through the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee, providing additional indirect economic exposure to Alignment Healthcare stock.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported a Form 4 showing a bona fide gift of 4,200 shares of common stock to family members on March 10, 2026. The transaction carried no sale price, and she now directly holds 992,815 shares after the gift.
Alignment Healthcare, Inc. notice of sale of 69,541 shares of Common Stock. The filing lists the sale date as 12/29/2025 and an aggregate transaction amount of $1,303,384.48.
The shares were acquired on 03/08/2022 upon vesting of restricted stock units granted under the 2021 Equity Incentive Plan. The filing identifies the seller as Robert L. Scavo.
Alignment Healthcare, Inc. submitted a Rule 144 notice relating to planned sales of Common Stock by a selling holder under existing 10b5-1 Sales Plan arrangements. The filing lists multiple executed or scheduled dispositions by Dawn Maroney, including sales of 100,000 shares on 01/02/2026 and 228,152 shares on 01/06/2026. Shares outstanding were 204,296,493 as of 03/11/2026.